alexa ω-3 Polyunsaturated Fatty Acids on the Prognosis
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

ω-3 Polyunsaturated Fatty Acids on the Prognosis of Multiple Sclerosis: The Effect of Eicosapentaenoic acid

Serafina Salvati* and Antonella Di Biase

Department Veterinary Public Health & Food Safety-IstitutoSuperiore di Sanità-Rome, Italy

Corresponding Author:
Serafina Salvati
Department Veterinary Public Health & Food Safety
IstitutoSuperiore di Sanità, Rome, Italy
Tel: +390649902574
Fax: +390649387149
E-mail: [email protected]

Received date: December 26, 2013; Accepted date: February 19, 2014; Published date: February 27, 2014

Citation: Salvati S, Di Biase A (2014) ω-3 Polyunsaturated Fatty Acids on the Prognosis of Multiple Sclerosis: The Effect of Eicosapentaenoic acid. J Neurol Neurophysiol S12:009. doi:10.4172/2155-9562.S12-009

Copyright: © 2014 Salvati S, et al. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



The effect of nutrition and dietary supplements on the course of multiple sclerosis is a topic of great interest
to both patients and clinicians. The influence of ω-3 polyunsaturated fatty acids (PUFAs) on the development and
course of multiple sclerosis (MS) has been under investigation. A number of small, uncontrolled clinical trials with
fish oil (rich in eicosapentaenoic acid (EPA; 20:5 ω-3) and docosahexaenoic acid (DHA; 22:6 ω-3) have indicated
a possible beneficial effects of ω-3 PUFAs, but controlled trials have not been able to draw definitive conclusions.
Among ω-3 PUFAs, EPA has the most potent effect on myelinogenesis and inflammatory process, thus the conflicting
results could be due to the different mixtures of EPA and DHA contained in the various sources of fish oil. This review
discusses on the possible role of EPA in demyelinating diseases.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version